Despite PTEN/PI3K/AKT/mTOR pathway is considered a hallmark of GBM and the inhibition of this pathway represents to date an interesting strategy against this lethal tumor [1, 42], the direct evaluation of this pathway activation in GBM patients is not routinely performed or standardized and results are still controversial. Here, MTOR is linked to neoplasm.